Brief: Bluebird Bio Confirms That Ayrmid, Has Not Delivered A Binding Offer Or Obtained Necessary Financing Despite Extensive Engagement
16/04/2025 13:25
April 16 (Reuters) - bluebird bio Inc BLUE.O: BLUEBIRD BIO CONFIRMS THAT AYRMID, LTD. HAS NOT DELIVERED A BINDING OFFER OR OBTAINED NECESSARY FINANCING DESPITE EXTENSIVE ENGAGEMENT BLUEBIRD BIO INC - BOARD REAFFIRMS SUPPORT FOR CARLYLE AND SK CAPITAL DEAL BLUEBIRD BIO INC - AYRMID ACKNOWLEDGES LACK OF NECESSARY FINANCING FOR PROPOSAL BLUEBIRD BIO INC - AT RISK OF DEFAULTING ON LOAN COVENANTS Source text: ID:nBw7dXX8Ma Further company coverage: BLUE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on bluebird bio
See all newsBrief: Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital
Brief: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
Brief: Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment